Generated by DeepSeek V3.2| Leidos | |
|---|---|
| Name | Leidos |
| Type | Public |
| Traded as | NYSE: LDOS |
| Industry | Information technology, defense, Aviation, Health care |
| Founded | 0 1969 (as SAIC) |
| Founder | J. Robert Beyster |
| Hq location | Reston, Virginia, United States |
| Key people | Thomas A. Bell (Chairman), Thomas J. Roden (CEO & President) |
| Num employees | ~47,000 (2024) |
| Revenue | ▲ US$15.4 billion (2023) |
| Net income | ▲ US$1.0 billion (2023) |
Leidos. It is a major American company specializing in information technology, defense, and biomedical research, providing scientific, engineering, and systems integration services primarily to agencies of the United States government. Formed from the 2013 spin-off of the legacy SAIC, the company holds significant contracts with the Department of Defense, the Department of Homeland Security, and the NASA. Headquartered in Reston, Virginia, Leidos operates globally, delivering solutions in areas such as national security, cybersecurity, health informatics, and civil engineering.
The company's origins trace back to 1969 when nuclear physicist J. Robert Beyster founded SAIC in San Diego, California. Initially focused on providing technical services related to nuclear power and national security, SAIC grew rapidly during the Cold War, becoming a leading contractor for the Department of Energy and the Pentagon. In 2013, the original SAIC executed a spin-off, creating two separate publicly traded entities: the legacy company retained the SAIC name, while the larger services and solutions business was renamed Leidos, a name derived from the word "kaleidoscope" to reflect a broad range of capabilities. A pivotal moment in its expansion occurred in 2016 when Leidos completed a major merger with the information systems and global solutions units of Lockheed Martin, significantly bolstering its scale in defense technology and healthcare IT.
Leidos organizes its vast portfolio into several core business segments delivering advanced technological solutions. The Defense Systems group focuses on airborne reconnaissance, C4ISR systems, logistics, and simulation and training for military clients like the U.S. Army and U.S. Air Force. The Civil segment provides IT infrastructure, enterprise modernization, and mission support to civilian agencies including the FAA, the EPA, and the IRS. Its Health and Energy sector supports biomedical research for the NIH, manages clinical trials, and delivers health information exchange systems, while also undertaking projects for the Department of Energy.
As a publicly traded corporation on the New York Stock Exchange under the ticker LDOS, Leidos is governed by a board of directors chaired by Thomas A. Bell. The company's operational leadership is under CEO and President Thomas J. Roden, who oversees a decentralized structure of business groups and subsidiaries. Major wholly-owned subsidiaries include QTC Management, a leading provider of government-outsourced disability and occupational health examinations, and Lockheed Martin IS&GS-inherited assets. Its global footprint includes significant operations across the United Kingdom, Australia, and Saudi Arabia, supporting allied governments and international partners.
The company has demonstrated consistent financial growth, driven by its diverse contract base and strategic acquisitions. For the 2023 fiscal year, Leidos reported total revenue of US$15.4 billion, a notable increase from prior years, with a net income reaching approximately US$1.0 billion. Key financial metrics show strong cash flow from operations, which supports ongoing research and development investments and shareholder returns through dividend payments and share repurchase programs. Its financial stability is closely tied to the federal budget cycles of its primary government customers.
Leidos secures and executes some of the most substantial government technology contracts in the United States. A flagship program is the NGEN-R (Next Generation Enterprise Network-Recompete) contract with the U.S. Navy, valued in the billions, to modernize and manage the Navy's information technology infrastructure. Another critical project is the MHS Genesis program, a joint Department of Defense and Veterans Affairs initiative to deploy a single, integrated electronic health record system across military health facilities. The company also provides end-to-end mission support for NASA's ISS and deep space exploration programs, including the Space Launch System.
Executive leadership is composed of seasoned professionals from the defense industry, information technology, and public sector. Thomas J. Roden, appointed CEO in 2023, previously served as COO and has held leadership roles since the Lockheed Martin integration. The board of directors includes figures like former CIA Deputy Director David S. Cohen and retired U.S. Navy Admiral James G. Stavridis, providing deep expertise in national security and international relations. Corporate governance follows NYSE listing standards, with committees overseeing audit, compensation, and governance matters to ensure accountability and ethical conduct. Category:Companies based in Virginia Category:Defense companies of the United States Category:Information technology companies of the United States